<p><REFSHEAD>References</p><p><REFS>1. Stehlik J, Hosenpud JD, Edwards LB, et al. ISHLT International Registry for Heart </p><p> and Lung Transplantation – into the fourth decade, from strength to strength. J Heart </p><p>Lung Transplant 2013;32:941–50.</p><p>2. Barnard CN. The operation. A human cardiac transplant: an interim report of a successful </p><p> operation per- formed at Groote Schuur Hospital, Cape Town. S Afr Med J </p><p>1967;41:1271–4.</p><p>3. Dipchand AI, Kirk R, Edwards LB, et al. The Registry of the International Society for Heart </p><p> and Lung Transplantation: sixteenth official pediatric heart transplantation report – </p><p>2013; focus theme: age. J Heart Lung Transplant 2013;32:979–88.</p><p>4. Canter CE, Shaddy RE, Bernstein B, et al. Indications for heart transplantation in pediatric </p><p> heart disease: a scientific statement from the American Heart Association Council on </p><p>Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular </p><p>Nursing, and Cardio- vascular Surgery and Anesthesia; and the Quality of Care and </p><p>Outcomes Research Interdisciplinary Working Group. Circulation 2007;115:658–76.</p><p>5. Kirklin JK, Naftel DC, Caldwell RL, et al. Should status II patients be removed from the </p><p> pediatric heart transplant waiting list? A multi-institutional study. J Heart Lung </p><p>Transplant 2006;25:271–5.</p><p>6. Fricker FJ, Addonizio L, Bernstein D, et al. Heart transplantation in children: indications. </p><p>Pediatr Transplant 1999;3:333–42.</p><p>7. Jenkins PC, Flanagan MF, Sargent JD, et al. A comparison of treatment strategies for </p><p> hypoplastic left heart syndrome using decision analysis. J Am Coll Cardiol </p><p>2001;38:1181–7.</p><p>8. Shaddy RE, Parisi F. Pediatric heart transplantation. In: Allen HD, Driscoll DJ, Shaddy RE, </p><p>Feltes TF (eds) Moss and Adams’ Heart Disease in Infants, Children, and Adolescents </p><p>Including the Fetus and Young Adult, 8th edn. Philadelphia: Lippincott, Williams & </p><p>Wilkins, 2013 pp. 1384–400. 9. Davies RR, Russo MJ, Mital S, et al. Predicting survival among high-risk pediatric cardiac </p><p> transplant recipients: an analysis of the United Network for Organ Sharing database. J </p><p>Thorac Cardiovasc Surg 2008;135:147–55.</p><p>10. Kimberling MT, Balzer DT, Hirsch R, et al. Cardiac transplantation for pediatric </p><p> restrictive cardiomyopathy: presentation, evaluation and short-term outcome. J Heart </p><p>Lung Transplant 2002;21:455–9.</p><p>11. Pollock-BarZiv SM, den Hollander N, Ngan BY, et al. Pediatric heart transplantation in </p><p> human leukocyte antigen sensitized patients: evolving management and assessment of </p><p> intermediate-term outcomes in a high-risk population. Circulation 2007;116:I172–8.</p><p>12. Holt DB, Lublin DM, Phelan DL, et al. Mortality and morbidity in pre-sensitized pediatric </p><p> heart transplant recipients with a positive donor crossmatch utilizing peri-operative </p><p> plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007;26:876–82.</p><p>13. Feingold B, Bowman P, Zeevi A, et al. Survival in al- losensitized children after listing for </p><p> cardiac transplantation. J Heart Lung Transplant 2007;26:565–71.</p><p>14. Stastny P, Lavingia B, Fixler DE, et al. Antibodies against donor human leukocyte </p><p> antigens and the outcome of cardiac allografts in adults and children. Transplantation </p><p>2007;84:738–45.</p><p>15. Wright EJ, Fiser WP, Edens RE, et al. Cardiac trans- plant outcomes in pediatric patients </p><p> with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective </p><p> crossmatch. J Heart Lung Transplant 2007;26:1163–9.</p><p>16. West LJ, Pollock-Barziv SM, et al. ABO-incompatible heart transplantation in infants. N </p><p>Engl J Med 2001;344:793–800.</p><p>17. Henderson HT, Canter CE, Mahle WT, et al. ABO-incompatible heart transplantation: </p><p> analysis of the Pediatric Heart Transplant Study (PHTS) database. J Heart Lung </p><p>Transplant 2012;31:173–9.</p><p>18. Urschel S, Larsen IM, Kirk R, et al. ABO-incompatible heart transplantation in early </p><p> childhood: an international multicenter study of clinical experiences and limits. J Heart Lung Transplant 2013;32:285–92.</p><p>19. Morrow WR. Cardiomyopathy and heart transplantation in children. Curr Opin Cardiol </p><p>2000;15:216–23.</p><p>20. Mital S, Addonizio LJ, Lamour JM, et al. Outcome of children with end-stage congenital </p><p> heart disease waiting for cardiac transplantation. J Heart Lung Transplant 2003;22:147–</p><p>53.</p><p>21. Gajarski RJ, Mosca RS, Ohye RG, et al. Use of extracorporeal life support as a bridge to </p><p> pediatric cardiac transplantation. J Heart Lung Transplant 2003;22:28–34.</p><p>22. Morrissey PE, Monaco AP. Donation after circulatory death: current practices, ongoing </p><p> challenges, and potential improvements. Transplantation 2014;97:258–64.</p><p>23. Gries CJ, White DB, Truog RD, et al. An official American Thoracic Society/International </p><p>Society for Heart and Lung Transplantation/Society of Critical Care </p><p>Medicine/Association of Organ and Procurement Organizations/United Network of </p><p>Organ Sharing Statement: ethical and policy considerations in organ donation after </p><p> circulatory determination of death. Am J Respir Crit Care Med 2013;188:103–9. </p><p>24. Harrison CH, Laussen PC. Controversy and consensus on pediatric donation after cardiac</p><p> death: ethical issues and institutional process. Transplant Proc 2008; 40: 1044–7.</p><p>25. Ford MA, Almond CS, Gauvreau K, et al. Association of graft ischemic time with survival </p><p> after heart transplant among children in the United States. J Heart Lung Transplant </p><p>2011;30:1244–9. </p><p>26. Sarti A. Organ donation. Paediatr Anaesth 1999;9:287–94.</p><p>27. Ullah S, Zabala L, Watkins B, et al. Cardiac donor organ management. Perfusion </p><p>2006;21:93–8.</p><p>28. Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the canine heart. </p><p>Surg Forum 1960;11:18–25. 29. Khonari S, Sintek CF, Ardehali A. Cardiac surgery: safeguards and pitfalls in operative </p><p> technique. Philadelphia, PA: Lippincott Williams & Wilkins, 2008, p. 190.</p><p>30. Schnoor M, Schäfer T, Lü hmann D, et al. Bicaval versus standard technique in orthotopic</p><p> heart transplantation: a systematic review and meta-analysis. J Thorac Cardiovasc Surg </p><p>2007;134:1322–31.</p><p>31. Weiss ES, Nwakanma LU, Russell SB, et al. Outcomes in bicaval versus biatrial techniques</p><p> in heart transplantation: an analysis of the UNOS database J Heart Lung Transplant </p><p>2008;27:178–83.</p><p>32. Rivenes SM, Lewin MB, Stayer SA, et al. Cardiovascular effects of sevoflurane, isoflurane, </p><p> halothane, and fentanyl–midazolam in children with congenital heart disease: an </p><p> echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology </p><p>2001;94:223–9.</p><p>33. Schure AY, Kussman BD. Pediatric heart transplantation: demographics, outcomes, and </p><p> anesthetic implications. Paediatr Anaesth 2011;21:594–603. </p><p>34. Schumacher KR, Gajarski RJ. Postoperative care of the transplanted patient. Curr Cardiol </p><p>Rev 2011;7:110–22.</p><p>35. Sawasdiwipachai P, Laussen PC, McGowan FX, et al. Cardiac arrest after neuromuscular </p><p> blockade reversal in a heart transplant infant. Anesthesiology 2007;107:663–5.</p><p>36. Backman SB (2008) Anticholinesterase drugs and the transplanted heart. </p><p>Anesthesiology 2008;108:965.</p><p>37. Lin C, Chan K, Chou Y, et al. Transesophageal echocardiography monitoring of </p><p> pulmonary venous struction induced by sternotomy closure during infant heart </p><p> transplantation. Br J Anaesth 2002;88:590–952.</p><p>38. Dietl W, Bauer M, Podesser BK. Nitric oxide in cardiac transplantation. Pharmacol Rep </p><p>2006;58 145–152. 39. Mitchell MB, Campbell DN, Bielefeld MR, et al. Utility of extracorporeal membrane </p><p> oxygenation for early graft failure following heart transplantation in infancy. J Heart </p><p>Lung Transplant 2000;19:834–839.</p><p>40. Ibrahim JE, Sweet SC, Flippin M, et al. Rejection is reduced in thoracic organ recipients </p><p> when transplanted in the first year of life. J Heart Lung Transplant 2002;21:311– 318.</p><p>41. Rochea SL, Burch M, O’Sullivana J, et al. Multicenter experience of ABO-incompatible </p><p> pediatric cardiac trans- plantation. Am J Transplant 2008;8:208–215.</p><p>42. Reddy SC, Laughlin K, Webber SA, et al. Immunosuppression in pediatric heart </p><p> transplantation: 2003 and beyond. Curr Treat Options Cardiovasc Med 2003;5:417–428.</p><p>43. Chan M, Pearson GJ. New advances in antirejection therapy. Curr Opin Cardiol </p><p>2007;22:117–122.</p><p>44. Patel JK, Kobashigawa JA. Tacrolimus in heart transplant patients: an overview. Biodrugs</p><p>2007;21:139–143.</p><p>45. Zuckermann A, Manito N, Epailly E, et al. Multidisciplinary insights on clinical guidance </p><p> for the use of proliferation signal inhibitors in heart transplantation. J Heart Lung </p><p>Transplant 2008;27:141–149.</p><p>46. Pahl E. Statins in the prevention of transplant coronary artery disease: in pediatric heart </p><p> recipients. Pediatr Transplantation 2007;11:459–460.</p><p>47. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for </p><p> the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung </p><p>Transplant 2005;24:1710–1720.</p><p>48. Law YM. Pathophysiology and diagnosis of allograft rejection in pediatric heart </p><p> transplantation. Curr Opin Cardiol 2007;22:66–71.</p><p>49. Leonard GTJr, Fricker FJ, Pruett D, et al. Increased, myocardial performance index </p><p> correlates with biopsy- proven rejection in pediatric heart transplant recipients. J Heart </p><p>Lung Transplant 2006;25:61–66.</p><p>50. Behera SK, Trang J, Feeley BT, et al. The use of Doppler tissue imaging to predict cellular and antibody-mediated re- jection in pediatric heart transplant recipients. Pediatr </p><p>Transplant 2008;12:207–214.</p><p>51. Mondillo S, Maccherini M, Galderisi M. Usefulness and limitations of transthoracic </p><p> echocardiography in heart transplantation recipients. Cardiovasc Ultrasound 2008;6:2.</p><p>52. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation </p><p>2008;117:2131–2141.</p><p>53. Maiers J, Roger Hurwitz R. Identification of coronary artery disease in the pediatric </p><p> cardiac transplant patient. Pediatr Cardiol 2008;29:19–23.</p><p>54. Labarrere CA, Nelson DR, Park JW. Pathologic markers of allograft arteriopathy: insight </p><p> into the pathophysiology of cardiac allograft chronic rejection. Curr Opin Cardiol </p><p>2001;16:110–117.</p><p>55. Schowengerdt KO, Naftel DC, Seib PM, et al. Infections after pediatric heart </p><p> transplantation: results from a multi-institutional study. J Heart Lung Transplant </p><p>1997;16:1207–1216.</p><p>56. Kulikowska A, Boslaugh SE, Huddleston CB, et al. Infectious, malignant, and autoimmune </p><p> complications in pediatric heart transplant recipients. J Pediatr 2008;152:671– 6777.</p><p>57. Lee CK, Christensen LL, Magee JC, et al. Pre- transplant risk factors for chronic renal </p><p> dysfunction after pediatric heart transplantation: a 10-year national cohort study. J </p><p>Heart Lung Transplant 2007;26:458–465.</p><p>58. Rakhit A, Nurko S, Gauvreau K, et al. Gastrointestinal complications after pediatric </p><p> cardiac transplantation. J Heart Lung Transplant 2002;21:751–759.</p><p>59. Davis JA, McBride MG, Chrisant MR, et al. Longitudinal assessment of cardiovascular </p><p> exercise performance after pediatric heart transplantation. J Heart Lung Transplant </p><p>2006;25:626–633</p><p>60. Abarbanell G, Mulla N, Chinnock R, et al. Exercise assessment in infants after cardiac </p><p> transplantation. J Heart Lung Transplant 2004;23:1334–1338.</p><p>61. Todaro JF, Fennell EB, Sears SF, et al. Review: cognitive and psychological outcomes in pediatric heart transplantation. J Pediatr Psychol 2000;25:567–576.</p><p>62. Simons LE, Anglin G, Warshaw BL, et al. Understanding the pathway between the </p><p> transplant experience and health-related quality of life outcomes in adolescents. Pediatr </p><p>Transplant 2008;12:187–193.</p><p>63. Young GS, Mintzer LL, Seacord D, et al. Symptoms of posttraumatic stress disorder in </p><p> parents of transplant recipients: incidence, severity, and related factors. Pediatrics </p><p>2003;111:725–731.</p><p>64. Wernovsky G, Newburger J. Neurologic and develop- mental morbidity in children with </p><p> complex congenital heart disease. J Pediatr 2003;142:6–8.</p><p>65. Khagani A, Santini F, Dyke CM, et al. Heterotopic car- diac transplantation in infants and </p><p> children. J Thorac Cardiovasc Surg 1997;113:1042–1049.</p><p>66. Astora TL, Galantowicz M, Phillips A, et al. Domino heart transplantation involving </p><p> infants. Am J Transplant 2007;7:2626–2629.</p><p>67. Manzoni D, D’Ercole C, Spotti A, et al. Congenital heart disease and pediatric liver </p><p> transplantation: complications and outcome. Pediatr Transplant 2007;11:876–881.</p><p>68. Asrani SK, Asrani NS, Freese DK, et al. Congenital heart disease and the liver. Hepatology </p><p>2012;56:1160–9.</p><p>69. Camposilvan S, Milanesi O, Stellin G, et al. Liver and cardiac function in the long term </p><p> after Fontan operation. Ann Thorac Surg 2008;86:177–182. </p><p>70. Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or </p><p> transplantation in patients after Fontan surgery. Heart 2013;99:491–6. </p><p>71. Concejero A, Chen CL, Liang CD, et al. Atrial septal defect in end-stage liver disease </p><p> children before and after liver transplantation. Surgery 2008;143:271–277. </p><p>72. Krowka MJ, Miller DP, Barst RJ, et al. Portopulmonary hypertension: a report from the </p><p>US-based REVEAL Registry. Chest 2012;141:906–15. 73. Feier FH, Neto JS, Porta G, et al. Liver transplantation after stage II palliation for </p><p> hypoplastic left heart syndrome. Liver Transpl 2013;19:322–7. </p><p>74. Cannon RM, Hughes MG, Jones CM, et al.. A review of the United States experience with </p><p> combined heart-liver transplantation. Transpl Int 2012;25:1223–8.</p><p>75. Khan MS, Heinle JS. Pediatric thoracic multiorgan transplantation. Tex Heart Inst J </p><p>2012;39:850–1. </p><p>76. Hollander SA, Reinhartz O, Maeda K, et al. Intermediate-term outcomes after combined </p><p> heart-liver transplantation in children with a univentricular heart. J Heart Lung </p><p>Transplant 2013;32:368–70. </p><p>77. Hennessey T, Backman SB, Cecere R, et al. Combined heart and liver transplantation on </p><p> cardiopulmonary bypass: report of four cases. Can J Anaesth 2010;57:355–60. </p><p>78. Rauchfuss F, Breuer M, Dittmar Y, et al. Implantation of the liver during reperfusion of </p><p> the heart in combined heart-liver transplantation: own experience and review of the </p><p> literature. Transplant Proc 2011;43:2707–13. </p><p>79. Hill AL, Maeda K, Bonham CA, Concepcion W. Pediatric combined heart-liver </p><p> transplantation performed en bloc: a single-center experience. Pediatr Transplant </p><p>2012;16:392–7. </p><p>80. Giakoustidis A, Cherian TP, Antoniadis N, Giakoustidis D. Combined cardiac surgery and </p><p> liver transplantation: three decades of worldwide results. J Gastrointestin Liver Dis </p><p>2011;20:415–21. </p><p>81. Porrett PM, Desai SS, Timmins KJ, et al. Combined orthotopic heart and liver </p><p> transplantation: the need for exception status listing. Liver Transpl 2004;10:1539–1544.</p><p>82. Topilsky Y, Raichlin E, Hasin T, et al. Combined heart and liver transplant attenuates </p><p> cardiac allograft vasculopathy compared with isolated heart transplantation. </p><p>Transplantation 2013 27;95:859–65. </p><p>83. Johnson MR, Aaronson KD, Canter CF, et al. Heart retransplantation. Am J Transplant 2007;7:2075–2081.</p><p>84. Clark JB, Pauliks LB, Myers JL, Undar A. Mechanical circulatory support for end-stage </p><p> heart failure in repaired and palliated congenital heart disease. Curr Cardiol Rev </p><p>2011;7:102–9.</p><p>85. Matsa E, Sallam K, Wu JC. Cardiac stem cell biology: glimpse of the past, present, and </p><p> future. Circ Res 2014;114:21–7.</p><p>86. Hirt MN, Hansen A, Eschenhagen T. Cardiac tissue engineering: state of the art. Circ Res </p><p>2014 ;114:354–67.</p><p>87. Lee AY, Mahler N, Best C, et al Regenerative implants for cardiovascular tissue </p><p> engineering. Transl Res 2014;163:321–341.</p><p>88. Manji RA, Ekser B, Menkis AH, Cooper DK. Bioprosthetic heart valves of the future. </p><p>Xenotransplantation 2014 ;21:1–10Jan 21. doi: 10.1111/xen.12080. [Epub ahead of </p><p> print].</p><p>89. Conway J, Manlhiot C, Kirk R, et al. Mortality and morbidity after retransplantation after </p><p> primary heart transplant in childhood: an analysis from the registry of the International </p><p>Society for Heart and Lung Transplantation. J Heart Lung Transplant 2014;33:241–51. </p><p>90. Lala A, Joyce E, Groarke JD, Mehra MR. Challenges in long-term mechanical circulatory </p><p> support and biological replacement of the failing heart. Circ J 2014;78:288–99. </p><p>91. Brenden C Registry for the International Society for Heart and Lung transplantation: </p><p>Sixteenth Official Pediatric Lung and Heart/Lung Transplantation Report –2013. J Heart </p><p>Lung Transplant 2013; 32: 989–997. </p><p>92. Conrad C and Cornfield DN: Pediatric lung transplantation: promise being realized 2014:</p><p>Curr Opin Pediatr 2014, ;26: 1–9. </p><p>93. Corris PA: Lung transplantation for cystic fibrosis and bronchiectasis. Sem Respir Crit </p><p>Care Med 2013; 34: 297–304. 94. Aurora P, Carby M and Sweet S: Selection of cystic fibrosis patients for lung </p><p> transplantation. Curr Opin in Pul Med 2008,;14:589–594. </p><p>95. Elizur A, Sweet S, Huddleston CB et al:et al. Pre-transplant mechanical ventilation </p><p> increases short-term morbidity and mortality in pediatric patients with cystic fibrosis. J </p><p>Heart Lung Transplant 2007; 26:17–31.</p><p>96. Egan TM, Murray S, Bustami RT et al:et al. Development of the new lung allocation </p><p> system. Am J Transplant 2006; 6:1212–1227.</p><p>97.Munshi, L, Keshavjee S and Cypel M: Donor management and lung preservation for lung </p><p> transplantation. The Lancet Resp Med 2013;1:314–328. </p><p>98.Botha P, Rostron AJ, Fisher AJ et al:et al. Current strategies in donor selection and </p><p> management. Semin Thorac Cardiovasc Surg 2008; 20: 143–51.</p><p>99. Steen S, Ingemansson R, Eriksson et al:et al. First human transplantation of non </p><p> acceptable donor lung after reconditioning ex vivo. An Thorac Surg 2007; 83:2191–94.</p><p>100. Van Raemdonck D, Neyrinck A, Cypel M, Keshavjee S.: Ex-vivo lung perfusion. Transpl </p><p>Int 2014 Mar 15. doi: 10.1111/tri.12317. </p><p>101. Hoganson DM, Gazit AZ, Boson, US, Sweet SC, Grady RM, Huddlestom CB and Eghtesady </p><p>PE. Paracorporeal lung assist devices as a bridge to recovery ot lung transplantation in </p><p> neonates and young children. J Thorac Cardiovasc Surg 2014.; 147(1): 420–427.</p><p>102. Huddleston CB, Sweet SC, Mallory GB et al:et al. Lung transplant in very young infants. J</p><p>Thorac and Cardiovasc Surg 1999;118: 796–804.</p><p>103. Christie JD, Carby M, Bag R et al:et al. Report of the ISHLT working group on primary </p><p> lung graft dysfunction part II: definition. A consensus statement of the International </p><p>Society of Heart and Lung Transplanation. J Heart Lung Transplant 2005; 24:1454–59.</p><p>104. Suzuki Y, Cantu E and Christie J: Primary Graft Dysfunction. Semin Respir Crit Care Med</p><p>2013;34:305–319.</p><p>105. Carter YM, Yvette M, Gelman AE, Andrew E. and Kreisel, Daniel:. Pathogenesis, management and consequences of primary graft dysfunction. Semin Thorac Cardiovasc </p><p>Surg 2008; 20: 165–172.</p><p>106. Meyers BF, de la Morene M, Sweet S et al:et al. Primary graft dysfunction and other </p><p> selected complications of lung transplantation: a single center experience of 983 </p><p> patients. J Heart Lung Transplant 2005; ;129: 1421–29.</p><p>107. Daud SA, Yusen RD, Meyers BF et al: . Impact of immediate primary lung allograft </p><p> dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med </p><p>2007; ;175: :507–13.</p><p>108. Kimoff JR, Cheong TH, Cosio MG et al:et al. Pulmonary denervation in humans- </p><p> effects on dyspnea and ventilatory patterns during exercise Am J Respir Dis 1990;</p><p>;142: :1034–40.</p><p>109. Conrad I, Peggy S, Skaturd JB et al:et al. The Breuer- Hering reflex in humans. </p><p>Effects of pulmonary denervation and hypocapnia.: Am J Resip Crit Care Med 1995;</p><p>;152: :1747–1751.</p><p>110. Ling Z, Bernadette E, Grad DI et al:et al. Airway vascular changes in lung allograft </p><p> recipients. J Heart Lung Transplant 1999; ;18: :231–8</p><p>111. Cohen AH, Mallory GB, Ross K et al:et al. Growth of lungs after transplantation in </p><p> infants and children younger than three years of age. Am J Respir Crit Care Med </p><p>1999; ;159:1747–51.</p><p>112. Duebener LF, Takahashi Y, Wada H et al:et al. Do mature pulmonary lobes grow </p><p> after transplantation into immature recipient? Ann Thorac Surg 1999; ;68: :1165–</p><p>70.</p><p>113. Choong, CK., Sweet, SC., Bell, J et al:et al. Bronchial airway anastomotic </p><p> complications after pediatric lung transplantation: :Incidence, causes, </p><p> management and outcome. J Thorac and Cardiovasc Surg 2006; ;131:198–203.</p><p>114. Huddleston CC. Pediatric lung transplantation. Curr Treat Options Cardiovasc </p><p>Med . 2011;13:68–78. 115. Weight SS, DerHovanessian A, Wallace WD,Lynch JP and Belperido JA: </p><p>Bronchiolitis Obliterans Syndrome: The Achilles’ heel of lung transplantation. </p><p>Semin Respir Crit Care Med 2013;34:336–351.</p><p>116. Huddleston CB, Bloch JB, Sweet SC et al:et al. Lung transplantation in children. </p><p>Ann Surg 2002; ;236 (3): :270–76.</p><p>117. Date H, Yamane M, Toyooka S et al : Current status and potential of living-donor </p><p> lobar lung transplantation. Frontiers in bioscience 2008; ;13: :1433–39.</p><p>118. Kozower BD, Sweet SC, de la Morena M et al:et al. Living donor lobar grafts </p><p> improve pediatric lung retransplant survival. J Thorac Cardiovasc Surg 2006; ;131 </p><p>(5):1142–47.</p><p>119. Date H. Update on living-donor lobar lung transplantation. Curr Opin Organ </p><p>Transplant 2011;16:453–7. </p><p>120. Liou TG, Adler FR, Cox DR et al:et al. Lung transplantation and survival in children</p><p> with cystic fibrosis. N Engl J Med 2007; ;357: :2143–52. </p>